announcements monday, april 23: genomic equivalence, cloning, and stem cells: pp. 727-730 wednesday,...

20
Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789 Friday, April 27, 9 AM: optional review session Monday, April 30, 8 AM: final exam 139 points; 90 points from days 34-43; 49 points cumulative (days 1-43).

Upload: maximillian-melvyn-simmons

Post on 26-Dec-2015

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Announcements

• Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730

• Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

• Friday, April 27, 9 AM: optional review session

• Monday, April 30, 8 AM: final exam– 139 points; 90 points from days 34-43; 49 points

cumulative (days 1-43).

Page 2: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Outline/Learning objectives

A. CloningB. Embryonic Stem cells

After reading the text, attending lecture, and reviewing lecture notes, you should be able to:

• Describe the potential fates of stem cells in general.

• Distinguish reproductive cloning from therapeutic cloning.

• Describe how embryonic stem cells are obtained, how they are assayed for potency, and how they can be used.

Page 3: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Cloning Mammals: Evidence of nuclear equivalence and reprogramming

^ Cloned mice (b. 1998) and their “parents.” Coat color is used as a marker. Conclusion:Some differentiated nuclei can be completely reprogrammed.

Dolly (July 5, 1996 - Feb. 14, 2003)and one of her 6 lambs

Wilmut et al. 1997. Nature 385:810-814.

Black (ooplasm donor) Agouti (nucleus donor)

Albino (nucleus donor)Cloned mice (Agouti)

Page 4: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Two ways to make an embryo:1. Sexual reproduction

Source: Human Cloning and Genetic Modification: The Basic Science You Need to Know, Association of Reproductive Health Professionals, www. arhp.org

Page 5: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Two ways to make an embryo:2. Cloning or asexual reproduction

Source: www. arhp.org

“Nuclear Transplantation”

Page 6: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Human Reproductivevs. Therapeutic Cloning

Reproductive cloning• Goal is to produce a

clonal embryo to implant in a mother’s womb with intent to carry the child to birth.

Therapeutic cloning• Goal is to produce a

clonal embryo to generate embryonic stem cells.

• ES cells can be used to treat clonal donor without risk of immune rejection.

Page 7: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Top 10 causes of U.S. deaths (1998)

Cause # (1000’s) #/100,000 %1 Heart disease 724 268.2 31.02 Cancer 541 200.3 23.33 Stroke 158 58.6 6.84 Chronic lung disease 158 58.6 6.85 Accidents 98 36.2 4.26 Pneumonia/influenza 92 34.0 3.97 Diabetes 65 24.0 2.88 Suicide 31 11.3 1.39 Kidney disease 26 9.7 1.110 Chronic liver disease 25 9.3 1.1

Tissue damage, e.g. spinal cord injury, also potentially treatable with stem cells.

Page 8: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Study Suggests New Avenue on Diabetes

By THE ASSOCIATED PRESSPublished: April 11, 2007CHICAGO, April 10 (AP) —

Thirteen young diabetics in Brazil have been able to stop receiving insulin after being treated with stem cells taken from their own blood, researchers are reporting.

Page 9: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

What’s a stem cell?

• Stem cells are defined by their ability to:– Continue to grow and divide– Given the right signals (e.g. hormones

or growth/differentiation factors), to differentiate into a specialized cell type

• Stem cells have different potencies:– Unipotent: makes one cell type– Multipotent: makes several cell types– Pluripotent: makes most cell types– Totipotent: makes all possible cell

types (zygote)

Page 10: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Where do stem cells come from?

Page 11: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Evidence for ES cell pluripotency

Page 12: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Evidence of adult stem cell pluripotency

Page 13: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

But: the pleuropotency of adult stem cells may be exaggerated

• Many such studies have not been replicated.• In contrast, the totipotency of embryonic stem

cells is a fact.– However, the previously-approved lines have

dwindled and newer, better lines are not allowed.

• The Senate approved another stem cell bill 63-34. President Bush has vowed to veto it again.

Page 14: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Stem Cell Therapeutics

Page 15: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Some Stances on Human Cloning and Stem Cell Research

• Support any human cloning– Few biomedical scientists– Clonaid (Raelians - Bahamas), Severino Antinori (Italy), Panos

Zavos (Kentucky)

• Oppose reproductive cloning, support therapeutic cloning– Many biomedical scientists– Hatch-Feinstein-Specter-Kennedy et al. bill S.303 in U.S. Senate– Nancy Reagan

• Oppose any human cloning– Right-to-life groups: destruction of embryo, slippery slope– Brownback-Landrieu et al. bill S.245 in U.S. Senate– President Bush

Page 16: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

ES cells in the news: The mostspectacular fraud in biomedical research

• What three accomplishments did Dr. Hwang Woo Suk claim?1. First line of human embryonic stem cells generated from nucleus of

adult cell > first step in therapeutic cloning (2004). FRAUD2. Improvement in efficiency of above, generating ES cell lines from 9

patients > practical treatment through therapeutic cloning (Science 2005. 308:1777-1783). FRAUD

3. First cloning of a dog (Nature 2005. 436:641). VALIDATED

• What ethical breaches apparently occurred in his laboratory?1. Junior researchers were compelled to donate eggs for research in his

lab.2. Payments were made to egg donors through a Seoul hospital.3. He lied about it this knowledge to the journal Science.4. Dr. Woo Suk ordered subordinates to falsify data.

Page 17: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Korean Stem Cell Scandal, 2005-2006 (Hwang et al. 2005)

Duplicated

Duplicated

Cropped

Cropped

Cropped

Page 18: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Cancer cells defined by

1. Ability to proliferate uncontrollably• Causes tumor formation• Angiogenesis feeds the tumor• Cancer cells increase secretion of angiogenesis

activators and decrease angiogenesis inhibitors

2. Ability to spread through the body.• Invasion: cancer cells migrate into surrounding

tissues, blood vessels• Metastasis: cancer cells spread through

circulatory system to establish secondary tumors.

Page 19: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Normal versus tumor growth in skin

• Cancer cells don’t necessarily divide faster than normal cells.

• Normal: Rates of cell division and differentiation balanced.

• Tumor: Balance of cell division and cell differentiation favors cell division.

Page 20: Announcements Monday, April 23: genomic equivalence, cloning, and stem cells: pp. 727-730 Wednesday, April 25: cell biology of cancer, pp. 762-770, 775-789

Normal and transformed cell properties

Normal cells• Regulated growth

– Dependent on GF’s– Subject to cycle cycle control

• Anchorage-dependent• Contact inhibited (density-

dependent)• Subject to apoptosis• Flattened cells, normal

nuclei, normal chromosome number

Transformed (cancer) cells• Uncontrolled growth

– Independent of GF’s– Don’t obey checkpoints

• Anchorage-independent• Loss of contact inhibition >

pile up in culture• Escape apoptosis

pathways• Rounded cells, large nuclei,

abnormal chromosome number